🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5425
+0.0425 (8.50%)
At close: Nov 19, 2026, 4:00 PM EST
0.5409
-0.0016 (-0.29%)
After-hours: Nov 19, 2026, 7:58 PM EST

Humacyte Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Humacyte stock has a consensus rating of "Buy" and an average price target of $1.64. The average 1-year stock price forecast is 202.67% higher than the current stock price, while the lowest is $0.60 (+10.60%) and the highest is $4.00 (+637.33%).

Price Target: $1.64 (+202.67%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$0.60$1.64$1.13$4.00
Change+10.60%+202.67%+107.37%+637.33%

Analyst Ratings

The average analyst rating for Humacyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy333333
Buy111111
Hold111122
Sell000000
Strong Sell000000
Total555566

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Hold
Maintains
$1
HoldMaintains$1+84.33%Nov 16, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$1.25
BuyReiterates$1.25+130.41%Nov 12, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$4
BuyReiterates$4+637.33%Nov 11, 2026
BTIG
BTIG
Buy
Maintains
$2
BuyMaintains$2+268.66%Nov 11, 2026
Barclays
Barclays
Hold
Maintains
$0.5 → $0.6
HoldMaintains$0.5 → $0.6+10.60%Nov 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.04M
from 2.04M
Increased by 98.07%
Revenue Next Year
23.44M
from 4.04M
Increased by 480.72%
EPS This Year
-0.37
from -0.26
EPS Next Year
-0.25
from -0.37
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.26M1.57M--2.04M4.04M
Revenue Growth
-15.29%23.91%---98.07%
Operating Income
-81.21M-84.58M-96.94M-114.40M-107.44M-100.87M
Net Income
-26.48M-11.97M-110.78M-148.70M-40.83M-91.52M
EPS
-----0.26-0.37
Free Cash Flow
------52.00M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.2M
Avg4.0M
Low4.0M

Revenue Growth

Revenue Growth202620272028
High
108.2%
Avg
98.1%
Low
93.8%

EPS Forecast

EPS202620272028
High-0.35
Avg-0.37
Low-0.39

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-